Please login to the form below

Not currently logged in
Email:
Password:

PAD

This page shows the latest PAD news and features for those working in and with pharma, biotech and healthcare.

Citryll snares €15m backing for its autoimmune disease NETs

Citryll snares €15m backing for its autoimmune disease NETs

Other companies including Bristol-Myers Squibb (via its $600m acquisition of Padlock Therapeutics in 2016) are working on small-molecule PAD inhibitors for autoimmune disease. ... Citryll thinks however that its approach – which works downstream of PAD

Latest news

More from news
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • Changing healthcare communications Changing healthcare communications

    Admittedly, it’s not all roses around the layout pad and creative unicorns skipping through the office.

  • Mylan sees the UK paving the way for an insulin game changer Mylan sees the UK paving the way for an insulin game changer

    Mylan, the global healthcare company, has chosen the UK for the launch pad of its much-anticipated biosimilar version of the Sanofi blockbuster Lantus (insulin glargine), which it hopes will become

  • Deal Watch March 2016 Deal Watch March 2016

    Padlock's technology targets autoimmune disorders with protein/peptidyl arginine deiminase (PAD) inhibitors and offers the potential to prevent disease development in patients with early stage disease. ... Protein/peptidyl arginine deiminase (PAD)

  • Pharma deals in August 2015 Pharma deals in August 2015

    with two thirds voting in favour, which provides a firm launch pad for a formal offer.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics